| Literature DB >> 30909546 |
Jianguang Chen1, He Liu2, Zihao Xia3, Xiuxiang Zhao4, Yuanhua Wu5, Mengnan An6.
Abstract
Microbial secondary metabolites produced by actinomycetes are important natural products widely applied to control plant diseases. A variety of actinomycetes were isolated from soil samples collected from Tianzhu Mountain in Shenyang, China. A Streptomyces strain Shenyang Tianzhu (STZ) exhibits effective antiviral activity against Tobacco mosaic virus (TMV). The isolate was identified as Streptomyces ahygroscopicus based on its cultural, morphological, physiological, biochemical characteristics as well as the phylogenetic analysis using 16S rRNA sequences. To obtain the pure anti-TMV compound from Streptomyces STZ, the culture broth was subjected to Amberlite IRC-50 ion-exchange resin, SX-8 macroporous adsorption resin and Sephadex G-25 gel column chromatography. The purified active compound was confirmed to be ε-poly-l-lysine (ε-PL), with molecular mass in the range of 3454⁻4352 Da by structural analysis with infrared (IR), matrix-assisted laser desorption ionization-time-of-flight MS (MALDI-TOF), thin-layer chromatography (TLC) and high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR). The protective and curative effects of the purified compound ε-PL were tested and the results showed that the compound exhibited significant protective and curative activity against TMV. The potential application of ε-PL as an efficient anti-plant virus agent was expected.Entities:
Keywords: Streptomyces ahygroscopicus; anti-TMV activity; isolation and purification; structural determination; ε-poly-l-lysine
Mesh:
Substances:
Year: 2019 PMID: 30909546 PMCID: PMC6471872 DOI: 10.3390/molecules24061156
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1(A) Schematic representation of half-leaf method to study the anti-viral effect of the agent using N. glutinosa plants; (B) Inhibition effect of Streptomyces STZ fermentation broth against the TMV.
Physiological and biochemical characteristics of the strain STZ.
| Tests | Result | Tests | Result |
|---|---|---|---|
|
|
| ||
| Cellulose decomposition | − | + | |
| Starch hydrolysis | + | Sucrose | + |
| Gelatin hydrolysis | + | + | |
| Nitrate reduction | + | Starch | + |
| H2S production | − | Raffinose | − |
|
| + | ||
| 5 | + | Maltose | + |
| 7 | + | + | |
| 10 | − | Galactose | + |
|
| + | ||
| 20 | + | Inositol | + |
| 28 | + | − | |
| 37 | + | ||
| 50 | − |
+ positive; − negative.
Figure 2Phylogenetic analysis based on 16S rRNA gene sequences of Streptomyces STZ and species of the genus Streptomyces using the maximum likelihood method. Numbers on branch nodes are bootstrap values (1000 replicates).
Figure 3IR spectrum of the pure active compound isolated from Streptomyces STZ.
Figure 4(A) 1H-NMR spectrum of the pure active compound produced by Streptomyces STZ; (B) 13C-NMR spectrum of the pure active compound produced by Streptomyces STZ; (C) H-HCOSY spectrum of the pure active compound produced by Streptomyces STZ; (D) HSQC spectrum of the pure active compound produced by Streptomyces STZ; (E) HMBC spectrum of the pure active compound produced by Streptomyces STZ.
Figure 5MALDI-TOF MS spectrum of the purified active product from Streptomyces STZ.
Protection and curation effect of active compound against TMV.
| Compound Treatment | Protective Effect | Curative Effect |
|---|---|---|
| 500 μg/mL | 71.4 ± 1.7% | 59.3 ± 2.9% |
| 1000 μg/mL | 84.2 ± 3.2% | 68.7 ± 3.4% |